Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro

Oncology Reports

Volumn 10, Issue 4, 2003, Pages 967-971

  Igawa, Hideki ^a   Fujieda, Shigeharu ^a   Yuichikimura, ^a   Sugimoto, Chizuru ^a   Tanaka, Nobuyuki ^a   Ohtsubo, Toshto ^a   Kato, Yasushi ^a   Saito, Hitoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Cell cycle; Head and neck; PD ECGF thymidine phosphorylase; Tumor growth

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; ENZYME INHIBITOR; THYMIDINE PHOSPHORYLASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL CULTURE; CELL CYCLE; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEAD AND NECK TUMOR; HUMAN; IN VITRO STUDY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEAD AND NECK NEOPLASMS; HUMANS; THYMIDINE PHOSPHORYLASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 1542577509     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.4.967     Document Type: Article

References (30)

1. Miyazono K, Okabe T, Urabe A, Takaku F and Heldin CH: Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262: 4098-4103, 1987. (Pubitemid 17102635)
2. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M and Yamada Y: Angiogenic factor. Nature 356: 668, 1992.
3. Moghaddam A and Bicknell R: Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine Phosphorylase activity. Biochemistry 31: 12141-12146, 1992. (Pubitemid 23011359)
4. Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A and Heldin CH: Platelet-derived endothelial cell growth factor has thymidine Phosphorylase activity. Biochem Biophys Res Commun 184: 1311-1316, 1992.
5. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Utsuki K, Takaku F, Risau W and Heldin CH: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989. (Pubitemid 19102308)
6. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K and Akiyama S: Angiogenic activity of enzymes. Nature 368: 198, 1994.
7. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y and Akiyama S: Role of thymidine Phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine Phosphorylase. Cancer Res 55: 1687-1690, 1995.
8. Iltzssch M, Kouni M and Cha S: Kinetic studies of thymidine Phosphorylase from mouse liver. Biochemistry 24: 6799-6807, 1985. (Pubitemid 16170208)
9. O'Brien TS, Fox SB, Dickinson AJ, Turley H, Westwood M, Moghaddam A, Gatter KC, Bicknell R and Harris AL: Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 56: 4799-4804, 1996. (Pubitemid 26338087)
10. Maehara Y, Sakaguchi Y, Kusumoto T, Kusumoto H and Sugimachi K: Species differences in substrate specificity of pyrimidine nucleoside Phosphorylase. J Surg Oncol 42: 184-186, 1989. (Pubitemid 19285061)
11. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K and Akiyama S: Purification and tissue distribution of human thymidine Phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochem Biophys Acta 1034: 107-113, 1990. (Pubitemid 20114807)
12. Luccioni C, Beaumatin J, Bardot V and Lefrancois D: Pyrimidie nucleotide metabolism in human colon carcinomas: comparison of normal tissue, primary tumors and xenografts. Int J Cancer 58: 517-522, 1994. (Pubitemid 24268092)
13. Moghaddom A, Zhang HT, Fan TD, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL and Bicknell R: Thymidine Phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sei USA 92: 998-1002, 1995.
14. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H and Tominaga T: Expression of platelet-derived endothelial cell growth factor/thymidine Phosphorylase in human breast cancer. Int J Cancer 64: 79-82, 1995.
15. Fujieda S, Sunaga H, Tsuzuki H, Tanaka N and Saito H: Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma. Clin Cancer Res 4: 1583-1590, 1998. (Pubitemid 28304717)
16. Takao S, Takebayashi Y, Che X, Shinchi H, Natsugoe S, Miyadera K, Yamada Y, Akiyama S and AikouT: Expression of thymidine Phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin Cancer Res 4: 1619-1624, 1998. (Pubitemid 28304722)
17. Takebayayashi Y, Natsugoe S, Baba M, Akiba S, Fukumoto T, Miyadera K, Yamada Y, Takao S, Akiyama S and Aikou T: Thymidine Phosphorylase in human esophageal squamous cell carcinoma. Cancer 85: 282-289, 1999. (Pubitemid 29051280)
18. Fujimoto J, Sakaguchi H, Hirose R, Wen H and Tamaya T: Clinical implication of expression of platelet-derived endothelial cell growth factor (PD-ECGF) in metastatic lesions of uterine cevical cancers. Cancer Res 59: 3041-3044, 1999. (Pubitemid 29315997)
19. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
20. Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, Miyadera K, Yamada Y, Aikou T and Akiyama S: Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine Phosphorylase. Biochem Biophys Res Commun 253: 797-803, 1998. (Pubitemid 29039222)
21. Fukushima M, Suzuki N, Emura T, Yano S, Kazuno H, Toda Y, Yamada Y and Asao T: Structure and activity of specific inhibitor of thymidine Phosphorylase to potentiate the function of antitumor 2′-deoxyribonucleosides. Biochem Pharmacol 59: 1227-1236 2000. (Pubitemid 30157885)
22. Mizoguchi H, Komiyama S, Matsui K, Hamanaka M, Ono M, Kiue A, Kobayashi M, Shimizu N, Welgus HG and Kuwano M: The response to epidermal growth factor of human maxillary tumor cells in terms of tumor growth, invasion and expression of proteinase inhibitors. Int J Cancer 49: 738-743, 1991.
23. Kato Y, Matsukawa S, Muraoka R and Tanigawa N: Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine Phosphorylase cDNA. Br J Cancer 75: 506-511, 1997. (Pubitemid 27085290)
24. Sugimoto C, Fujieda S, Seki M, Sunaga H, Fan G-K, Tsuzuki H, Borner C, Saito H and Matsukawa S: Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo. Int J Cancer 82: 860-867, 1999. (Pubitemid 29384338)
25. Fujieda S, Zhang K and Saxon A: IL-4 plus CD40 monoclonal antibody induces human B cells g subclass-specific isotype switch: switching to g 1, g 3, and g 4, but not g 2. J Immunol 155:2318-2328,1995.
26. kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ 7: 699-710, 1996.
27. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF and Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685, 1995.
28. Kornmann M, Danenberg KD, Arber N, Beger HG, Danenberg PV and Korc M: Inhibition of cyclin Dl expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res 59: 3505-3511, 1999. (Pubitemid 29334515)
29. Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoto K, Akiba S, Miyadera K, Fukushima M, Yamada Y, Yoshida H, Kanzaki T and Akiyama S: The effect of a thymidine Phosphorylase inhibitor on angiogenesis and apoptosis in tumors. CancerRes 59: 1911-1916, 1999. (Pubitemid 29186165)
30. Takao S, Akiyama S, Nakajo A, Yoh H, Kitazono M, Natsugoe S and Miyadera K: Thymidine phophorylase inhibitor. Cancer Res 60: 5345-5348, 2000.